MINNEAPOLIS, July 28, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today ...
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (“Bruker”) (Nasdaq: BRKR) today announced it has commenced a public offering, subject to market and other conditions, of $600.0 million of ...
Shares of Bruker slipped after the maker of scientific products started a public offering of $600 million of Series A mandatory convertible preferred stock. The stock was 13% lower, at $28.86, midday ...
Many successful companies do stock splits to make their shares more affordable for retail investors. Hundreds of struggling companies are doing reverse stock splits to lift their flagging stocks above ...
Bruker Corporation (“Bruker”) (Nasdaq: BRKR) today announced the pricing of its previously announced public offering of $600.0 million of 6.375% Mandatory Convertible Preferred Stock, Series A, par ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results